Dr. Allison Betof Warner on Outcomes With Anti-PD1 Therapy in Melanoma

Leggi l'articolo originale


Cancer Network spoke with Allison Betof Warner, MD, PhD, of Memorial Sloan Kettering Cancer Center, about long-term outcomes and responses to retreatment in patients with melanoma receiving anti-PD1 therapy.

Lascia un commento